BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35750988)

  • 1. Whole-genome sequencing analysis of an atypical teratoid/rhabdoid tumor in a patient with Phelan-McDermid syndrome: a case report and systematic review.
    Yamashita H; Arakawa Y; Terada Y; Takeuchi Y; Mineharu Y; Sumiyoshi S; Tokunaga S; Nakajima K; Kawabata N; Tanaka K; Tanji M; Umeda K; Minamiguchi S; Ogawa S; Haga H; Takita J; Miyamoto S
    Brain Tumor Pathol; 2022 Oct; 39(4):232-239. PubMed ID: 35750988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22.
    Byers HM; Adam MP; LaCroix A; Leary SE; Cole B; Dobyns WB; Mefford HC
    Am J Med Genet A; 2017 Jan; 173(1):245-249. PubMed ID: 27734605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: The Emerging Role of Ring Chromosome 22 in Phelan-McDermid Syndrome With Atypical Teratoid/Rhabdoid Tumor: The First Child Treated With Growth Hormone.
    Crocco M; Panciroli M; Milanaccio C; Morerio C; Verrico A; Garrè ML; Di Iorgi N; Capra V
    Front Neurol; 2021; 12():741062. PubMed ID: 34777208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Array analysis and molecular studies of INI1 in an infant with deletion 22q13 (Phelan-McDermid syndrome) and atypical teratoid/rhabdoid tumor.
    Sathyamoorthi S; Morales J; Bermudez J; McBride L; Luquette M; McGoey R; Oates N; Hales S; Biegel JA; Lacassie Y
    Am J Med Genet A; 2009 May; 149A(5):1067-9. PubMed ID: 19334084
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical characterization of novel chromosome 22q13 microdeletions.
    Ha JF; Ahmad A; Lesperance MM
    Int J Pediatr Otorhinolaryngol; 2017 Apr; 95():121-126. PubMed ID: 28576520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromothripsis and ring chromosome 22: a paradigm of genomic complexity in the Phelan-McDermid syndrome (22q13 deletion syndrome).
    Kurtas N; Arrigoni F; Errichiello E; Zucca C; Maghini C; D'Angelo MG; Beri S; Giorda R; Bertuzzo S; Delledonne M; Xumerle L; Rossato M; Zuffardi O; Bonaglia MC
    J Med Genet; 2018 Apr; 55(4):269-277. PubMed ID: 29378768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case.
    Samogy-Costa CI; Varella-Branco E; Monfardini F; Ferraz H; Fock RA; Barbosa RHA; Pessoa ALS; Perez ABA; Lourenço N; Vibranovski M; Krepischi A; Rosenberg C; Passos-Bueno MR
    J Neurodev Disord; 2019 Jul; 11(1):13. PubMed ID: 31319798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fraternal twins with Phelan-McDermid syndrome not involving the SHANK3 gene: case report and literature review.
    Li S; Xi KW; Liu T; Zhang Y; Zhang M; Zeng LD; Li J
    BMC Med Genomics; 2020 Oct; 13(1):146. PubMed ID: 33023580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of metachromatic leukodystrophy in a patient with regression and Phelan-McDermid syndrome.
    Ahn H; Seo GH; Keum C; Heo SH; Kim T; Choi J; Yum MS; Lee BH
    Brain Dev; 2020 May; 42(5):414-417. PubMed ID: 32113700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 2 in Phelan-McDermid syndrome: Institutional experience and review of the literature.
    Ziats CA; Jain L; McLarney B; Vandenboom E; DuPont BR; Rogers C; Sarasua S; Nevado J; Cordisco EL; Phelan K; Boccuto L
    Eur J Med Genet; 2020 Nov; 63(11):104042. PubMed ID: 32822873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and genomic evaluation of a Chinese patient with a novel deletion associated with Phelan-McDermid syndrome.
    Lei D; Li S; Banerjee S; Zhang H; Li C; Hou S; Chen D; Yan H; Li H; Peng HH; Liu S; Zhang X; Peng Z; Wang J; Yang H; Huang H; Wu J
    Oncotarget; 2016 Dec; 7(49):80327-80335. PubMed ID: 27741506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the 22q13 region to explore the genetic and phenotypic diversity of patients with Phelan-McDermid syndrome.
    Vitrac A; Leblond CS; Rolland T; Cliquet F; Mathieu A; Maruani A; Delorme R; Schön M; Grabrucker AM; van Ravenswaaij-Arts C; Phelan K; Tabet AC; Bourgeron T
    Eur J Med Genet; 2023 May; 66(5):104732. PubMed ID: 36822569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlation in Phelan-McDermid syndrome: A comprehensive review of chromosome 22q13 deleted genes.
    Ricciardello A; Tomaiuolo P; Persico AM
    Am J Med Genet A; 2021 Jul; 185(7):2211-2233. PubMed ID: 33949759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional signatures of participant-derived neural progenitor cells and neurons implicate altered Wnt signaling in Phelan-McDermid syndrome and autism.
    Breen MS; Browne A; Hoffman GE; Stathopoulos S; Brennand K; Buxbaum JD; Drapeau E
    Mol Autism; 2020 Jun; 11(1):53. PubMed ID: 32560742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phelan McDermid Syndrome: five patients description and report on the first case described in conjoined twins].
    Canonero I; Montes C; Sturich A; Boterón M; Asinari M; Cuestas E; Rossi N
    Arch Argent Pediatr; 2012; 110(3):e50-4. PubMed ID: 22760760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient with the classic features of Phelan-McDermid syndrome and a high immunoglobulin E level caused by a cryptic interstitial 0.72-Mb deletion in the 22q13.2 region.
    Simenson K; Õiglane-Shlik E; Teek R; Kuuse K; Õunap K
    Am J Med Genet A; 2014 Mar; 164A(3):806-9. PubMed ID: 24375995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment.
    Ziats CA; Grosvenor LP; Sarasua SM; Thurm AE; Swedo SE; Mahfouz A; Rennert OM; Ziats MN
    PLoS One; 2019; 14(3):e0213921. PubMed ID: 30875393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
    Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W
    Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Goldenhar phenotype in a child with distal 22q11.2 deletion and intracranial atypical teratoid rhabdoid tumor.
    Lafay-Cousin L; Payne E; Strother D; Chernos J; Chan M; Bernier FP
    Am J Med Genet A; 2009 Dec; 149A(12):2855-9. PubMed ID: 19938088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of distal 22q11.2 deletion syndrome in a patient with a teratoid/rhabdoid tumour.
    Beddow RA; Smith M; Kidd A; Corbett R; Hunter AG
    Eur J Med Genet; 2011; 54(3):295-8. PubMed ID: 21187175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.